Travere Therapeutics logo
Travere Therapeutics TVTX
$ 15.21 1.0%

Quarterly report 2024-Q2
added 08-01-2024

report update icon

Travere Therapeutics Financial Ratios 2011-2024 | TVTX

Annual Financial Ratios Travere Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-6.8 -21.0 -9.1 -7.1 - - - - - - - - -

P/S

13.6 47.2 12.5 6.1 - - - - - - - - -

EPS

-1.2 -1.0 -3.0 -3.6 -3.5 -2.5 -1.5 -1.3 3.5 -4.4 -2.4 -8.3 -

EV (Enterprise Value)

1.14 B 1.95 B 1.95 B 1.51 B 321 M 288 M 128 M 177 M 175 M 155 M 32.8 M 55.6 K 54.2 K

EBITDA per Share

-0.75 -1.03 -3.12 -3.19 - - - - - - - - -

EV/EBITDA

-14.2 -35.2 - - - - - - - - -

PEG

- 0.49 - - - - - - - - -

P/B

3.1 32.3 5.4 5.7 - - - - - - - - -

P/CF

-2.2 -7.4 -111.2 -28.1 - - - - - - - - -

ROE %

-44.90 -153.61 -59.61 -80.22 - - - - - - - - -

ROA %

-11.43 -9.79 -23.19 -27.89 - - - - - - - - -

ROCE %

-46.93 -202.33 -66.01 -83.41 - - - - - - - - -

Current Ratio

1.3 1.1 1.6 1.5 - - - - - - - - -

DSO

153.2 202.5 44.1 31.3 - - - - - - - - -

DIO

222.1 488.7 713.2 407.8 - - - - - - - - -

DPO

939.8 1339.2 1303.8 1154.3 - - - - - - - - -

Operating Cycle

375.3 691.2 757.3 439.1 - - - - - - - - -

Cash Conversion Cycle

-564.6 -648.0 -546.5 -715.2 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Travere Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.91 -1.76 - 1.97 -1.13 -1.27 - -1.09 -1.05 -1.2 - -0.59 -0.64 -0.96 -2.37 -0.44 -0.58 0.02 -0.7 -0.85 -0.92 -0.99 -0.18 -1.34 -0.56 -0.46 -0.45 -0.46 -0.34 -0.29 -0.23 -1 -0.37 0.31 -0.07 2.95 -0.73 1.46 -1.1 -0.67 0.46 -3.25 -0.7 -0.71 -0.41 -0.46 -0.03 -2.42 -1.55 -1.43 -0.03 -0.1 - -

EBITDA per Share

-0.75 -1.68 - -1.07 -1.23 -1.33 - -1.21 -0.91 -0.94 - -0.18 -0.48 -0.74 -2.27 -0.03 -0.26 -0.22 -0.65 -0.45 -0.64 -0.8 -0.12 -0.54 -0.31 -0.34 -0.39 0.07 -0.12 -0.27 -0.48 -0.23 -0.1 -0.12 -0.42 -0.31 -0.04 -0.23 -0.72 -0.69 -0.6 -0.94 -0.64 -0.38 -0.4 -0.17 - -2.39 -1.53 -1.42 - - - -

ROE %

-540.77 -149.44 -65.28 -134.46 -257.53 -226.79 -148.46 -160.06 -102.46 -71.43 -38.19 -95.77 -94.85 -95.45 -80.22 -36.32 -42.14 -47.29 -66.20 -54.86 -55.49 -45.01 -32.26 -35.93 -24.87 -22.37 -20.38 -17.16 -23.15 -22.99 -15.56 -13.59 33.66 29.51 39.08 117.83 130.90 107.72 297.81 285.09 302.41 360.99 184.26 119.17 944.00 1807.53 2671.37 2671.92 1781.50 891.08 0.66 - - -

ROA %

2.92 4.06 -4.21 -13.80 -41.49 -39.04 -27.93 -32.53 -18.37 -23.59 -16.87 -36.89 -36.01 -35.08 -27.89 -12.87 -15.19 -17.30 -24.21 -20.26 -21.91 -18.66 -14.48 -16.81 -12.55 -11.94 -11.48 -9.73 -13.38 -13.39 -9.12 -7.96 19.71 17.28 22.89 1.94 -31.94 -18.24 -81.89 -123.01 -168.34 -201.07 -168.91 -106.51 -1316.86 -2561.79 -3806.99 -3824.81 -2555.87 -1286.92 -17.98 - - -

ROCE %

-701.14 -343.41 -173.81 -255.86 -304.82 -257.34 -155.59 -165.90 -94.17 -63.03 -34.05 -90.18 -89.07 -89.38 -83.41 -40.01 -46.38 -51.95 -62.10 -50.93 -46.54 -36.80 -25.15 -28.76 -21.20 -19.06 -18.35 -19.09 -22.09 -21.15 -18.91 -18.06 -18.28 -16.89 -16.92 38.34 103.88 152.32 214.24 224.42 198.65 179.75 130.82 318.70 534.01 645.87 491.75 491.75 243.50 104.42 - - - -

Current Ratio

1.0 1.1 1.3 1.5 1.2 1.3 1.1 1.2 - 1.3 1.6 1.7 1.8 1.9 1.5 1.5 1.5 1.5 1.6 1.6 1.6 1.6 1.8 1.8 1.8 1.8 2.3 2.3 2.3 2.3 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 0.8 0.8 0.8 0.8 0.5 0.5 0.5 0.5 0.4 - - 0.4 - - - -

DSO

39.8 48.4 - 43.0 59.4 56.4 - 20.6 12.4 28.8 - 16.9 20.8 27.9 28.5 28.4 30.0 32.5 35.3 37.1 36.8 35.4 26.4 28.4 27.9 31.5 30.0 31.4 32.6 43.9 - - - - - - - - - - - - - - - - - - - - - - - -

DIO

1888.0 2524.2 - 1399.5 800.5 123.7 - 298.9 145.1 295.2 - 401.9 403.2 410.2 - 583.9 464.7 455.9 - 366.8 566.9 524.9 - 452.6 435.3 310.3 - 527.9 - - - - - - - - - - - - 19.0 17.5 - - - - - - - - - - - -

DPO

942.3 1771.6 - 1580.5 1151.4 374.4 - 573.8 410.1 716.6 - 406.2 645.3 752.8 - 931.1 741.1 1290.4 - 1605.1 2480.6 1505.9 - 560.1 538.7 732.4 - 1868.2 - - - - - - - - - - - - 168.9 233.8 - - 905.3 224.5 - - - - - - - -

Operating Cycle

1927.8 2572.7 - 1442.5 860.0 180.1 - 319.4 157.4 324.0 - 418.8 424.1 438.1 28.5 612.3 494.7 488.4 35.3 403.9 603.7 560.3 26.4 480.9 463.2 341.8 30.0 559.2 32.6 43.9 - - - - - - - - - - 19.0 17.5 - - - - - - - - - - - -

Cash Conversion Cycle

985.5 801.0 - -138.0 -291.4 -194.4 - -254.3 -252.7 -392.6 - 12.6 -221.2 -314.6 28.5 -318.9 -246.4 -802.0 35.3 -1201.2 -1876.9 -945.6 26.4 -79.1 -75.5 -390.6 30.0 -1309.0 32.6 43.9 - - - - - - - - - - -150.0 -216.3 - - -905.3 -224.5 - - - - - - - -

All numbers in USD currency